Dual SGLT1 and SGLT2 inhibition: more than the sum of its parts

被引：1
|
作者：
Sanchez-Munoz, Enrique [1 ,2 ]
Requena-Ibanez, Juan Antonio [2 ]
Badimon, Juan Jose [1 ]
机构：
[1] Complejo Asistencial Univ Leon, Serv Cardiol, Leon, Spain
[2] Icahn Sch Med Mt Sinai, Mt Sinai Fuster Heart Hosp, Atherothrombosis Res Unit, New York, NY 10029 USA
来源：
REVISTA ESPANOLA DE CARDIOLOGIA | 2024年 / 77卷 / 07期
关键词：
D O I：
10.1016/j.rec.2024.01.011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：510 / 514
页数：5
相关论文
共 50 条
  • [41] Synthesis and biological evaluation of benzocyclobutane-C-glycosides as potent and orally active SGLT1/SGLT2 dual inhibitors
    Kuo, Gee-Hong
    Gaul, Micheal D.
    Liang, Yin
    Xu, June Z.
    Du, Fuyong
    Hornby, Pamela
    Xu, Guozhang
    Qi, Jenson
    Wallace, Nathaniel
    Lee, Seunghun
    Grant, Eugene
    Murray, William V.
    Demarest, Keith
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (07) : 1182 - 1187
  • [42] Localizations of Na+-d-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart
    Ivana Vrhovac
    Daniela Balen Eror
    Dirk Klessen
    Christa Burger
    Davorka Breljak
    Ognjen Kraus
    Nikola Radović
    Stipe Jadrijević
    Ivan Aleksic
    Thorsten Walles
    Christoph Sauvant
    Ivan Sabolić
    Hermann Koepsell
    Pflügers Archiv - European Journal of Physiology, 2015, 467 : 1881 - 1898
  • [43] LX4211, a dual inhibitor of SGLT2 and SGLT1 enhances the effects of sitagliptin in patients with type 2 diabetes mellitus
    Zambrowicz, B.
    Ogbaa, I.
    Powell, D.
    Banks, P.
    Turnage, A.
    Frazier, K.
    Boehm, K. A.
    Freiman, J.
    Lapuerta, P.
    Ruff, D.
    Sands, A.
    DIABETOLOGIA, 2012, 55 : S318 - S318
  • [44] Localizations of Na+-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart
    Vrhovac, Ivana
    Eror, Daniela Balen
    Klessen, Dirk
    Burger, Christa
    Breljak, Davorka
    Kraus, Ognjen
    Radovic, Nikola
    Jadrijevic, Stipe
    Aleksic, Ivan
    Walles, Thorsten
    Sauvant, Christoph
    Sabolic, Ivan
    Koepsell, Hermann
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2015, 467 (09): : 1881 - 1898
  • [45] The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus
    Pitt, Bertram
    Steg, Gabriel
    Leiter, Lawrence A.
    Bhatt, Deepak L.
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (03) : 561 - 567
  • [46] RENOPROTECTION WITH SGLT2 INHIBITION
    Komala, M. G.
    Gross, S.
    Pegg, K.
    Huang, C.
    Chen, J.
    Mather, A.
    Pollock, C.
    Panchapakesan, U.
    NEPHROLOGY, 2013, 18 : 56 - 56
  • [47] RENOPROTECTION WITH SGLT2 INHIBITION
    Panchapakesan, U.
    Forbes, J.
    Pegg, K.
    Mudaliar, H.
    Pollock, C.
    Mather, A.
    NEPHROLOGY, 2011, 16 : 33 - 33
  • [48] SGLT2 Inhibitors and Iron: More Than Meets the Eye
    Docherty, Kieran F.
    JACC-HEART FAILURE, 2023, 11 (11) : 1623 - 1625
  • [49] The Na+-D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer
    Koepsell, Hermann
    PHARMACOLOGY & THERAPEUTICS, 2017, 170 : 148 - 165
  • [50] An update of SGLT1 and SGLT2 inhibitors in early phase diabetes-type 2 clinical trials
    Adeghate, Ernest
    Mohsin, Sahar
    Adi, Faisal
    Ahmed, Fares
    Yahya, Ali
    Kalasz, Huba
    Tekes, Kornelia
    Adeghate, Ernest A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (09) : 811 - 820
12345